NeuroFlow

NeuroFlow is a provider of collaborative and measurement-based behavioral health tools for care settings. Its cloud-based tools for remote patient monitoring improve risk identification and facilitate collaborative care. It was founded by Adam Pardes and Chris Molaro (a former veteran) upon observing high levels of veteran suicide. NeuroFlow tracks brain signals and heart rate to measure a patient’s stress, relaxation and engagement levels. A therapist can monitor these signals, recognize what causes the patient to become uncomfortable and measure the probability of developing post-traumatic stress disorders (especially for veterans). It also leverages AI to support clinical decisions. While the main target audience is health systems, health plans and the military, a B2C version of NeuroFlow is also available, named NeuroFlow for individuals.

As of January 2021, the company had over 330,000 contracted users and was implemented at more than 200 healthcare facilities across the US.

Key customer and partnerships

In July 2023, NeuroFlow and healthcare provider Novant Health partnered to provide access to mental health services to patients and team members of Novant Health. Through the partnership, patients of Novant Health, aged 13 years and older, who are experiencing symptoms of depression gained have access to NeuroFlow’s mental health resources and support. The platform enabled constant monitoring of stress, relaxation, and engagement levels of patients, enabling timely interventions from clinicians where necessary. Additionally, Novant Health’s 36,000 employees also gained access to NeuroFlow’s self-care platform.

Funding and financials

In February 2023, the company received USD 500,000 for winning the US Department of Veterans Affairs’ (VA) mission daybreak challenge, which requires entrants to develop new strategies for preventing suicide in veterans. The company did not disclose what the funds would be used for.